Navigation Links
Biomatrica Secures Strategic Investment from IQT
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Biomatrica, Inc., a leader in room temperature biostability technology, today announced a strategic partnership agreement with In-Q-Tel (IQT). IQT is the independent, strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community.

Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples from purified DNA, RNA, and proteins as well as in complex systems such as tissue, cell lines, biopsies and whole blood. The company's products serve a wide range of customers such as those in the forensics, biomedical research (academic, government and industry), molecular diagnostics and biobanking. Biomatrica was recently recognized as a Finalist for the Most Innovative New Product Award (MIP) in the Life Science and Diagnostics category as conducted by San Diego's CONNECT.

"Biomatrica's technology capability is an important addition to our strategic investment portfolio," said Syd Ulvick, Vice President, Physical and Biological Technologies Practice at IQT. "The company's technology advances offer great promise for applications in both the government and commercial sector."

"As the needs of research and medicine to manage biological samples grow, increasing energy and environmental cost associated with cold storage of biological samples, it is critical for biobanks, research institutions and biotechnology companies to identify alternative storage solutions," said Judy Muller-Cohn, Ph.D., CEO and co-founder of Biomatrica. "The SampleMatrix technology allows for safe, long term preservation of biological samples at room temperature. Sample recovery is simple and sample integrity is assured."

SampleMatrix® is based on extremophile biology in which organisms are able to survive long-term in a state of anhydrobiosis (life without water) and later be revived by rehydration. Extremophiles such as tardigrades, also known as water bears, and brine shrimp are able protect their DNA, RNA, proteins, membranes and cellular systems in a dried state for extended periods of time. Biomatrica's technology mimics the natural molecular mechanisms used by these organisms. The technology works by forming a thermo-stable barrier during the drying process to protect samples from degradation during storage at room temperature.

About Biomatrica®, Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing and shipping biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA, RNA, proteins, cells and assays with no sample degradation, allowing scientists and clinicians to have pristine samples and reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this technology platform (DNAstable®, DNAstable Blood, DNAgard Tissue and DNAgard Blood for DNA, RNAstable® and RNAconcentrator for RNA, and CloneStable® for bacterial DNA), visit: www.biomatrica.com.

About IQT

In-Q-Tel is the strategic, not-for-profit investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the U.S. Intelligence Community. Launched in 1999 as a private, independent organization, IQT's mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States. Working from an evolving strategic blueprint defining the Intelligence Community's critical technology needs, IQT engages with entrepreneurs, growth companies, researchers, and investors to deliver technologies that provide superior capabilities for the CIA and the larger Intelligence Community. To learn more about IQT, visit www.iqt.org.


'/>"/>
SOURCE Biomatrica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
2. Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
3. Digital Assent Secures $2 Million Series A Financing to Grow PatientPad Point-of-Care Network
4. TechniScan Secures $10 Million Equity Financing Facility
5. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
6. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
7. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
8. Sutro Biopharma Secures $36.5 Million in Series C Financing
9. K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
10. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
11. Prolong Pharmaceuticals Secures $30 Million in Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 On Wednesday, February 22, 2017, ... out of nine sectors finished the trading sessions in green, ... closing. Major US indices were also mixed at the close ... 5,860.63, slightly down by 0.09%; the Dow Jones Industrial Average ... 500 closed at 2,362.82, down 0.11%. This Thursday morning, Stock-Callers.com ...
(Date:2/23/2017)... 2017 ML Capital Group, Inc. (USOTC: MLCG) ... Highlife Tours , a Colorado -based cannabis ... Puration, Inc. (USOTC: PURA) to enter Colorado,s ... Colorado Highlife Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... and VANCOUVER, British Columbia ... OGXI ) today announced its year end ... In January 2017, OncoGenex, and Achieve Life Science, ... they have entered into a definitive merger agreement under ... Upon completion of the proposed merger, Achieve,s stockholders are ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 2017 , ... Current Meditation , a new meditation ... the U.S. starting this spring. Current Meditation focuses on “meditation for the modern ... Meditation will be the first meditation concept in the U.S. offering franchising opportunities, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal dentist ... today with a new Indiegogo campaign . Individuals are now able to contribute ... Los Angeles area, either as a participating patient or through an Indiegogo donation. The ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... of a new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided ... nation’s largest healthcare systems recently invested $51 million to purchase and renovate the ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... secure messaging services to the largest network of hospitals, health information exchanges, ... National Coordinator for Health Information Technology (ONC-HIT) 2015 Edition Health IT Module Certification ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, ... or not filling a prescription because they could not afford to pay for ... medications were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and ...
Breaking Medicine News(10 mins):